Average Co-Inventor Count = 3.43
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck + Co., Inc. (59 from 4,770 patents)
2. Scifluor Life Sciences, Inc. (12 from 23 patents)
3. Merck Sharp + Dohme Corp. (2 from 2,405 patents)
4. Astrazeneca Ab (2 from 1,500 patents)
5. Ocuterra Therapeutics, Inc. (2 from 5 patents)
6. Link Medicine Corporation (2 from 2 patents)
7. Alairion, Inc. (1 from 1 patent)
79 patents:
1. 12497399 - Fluorinated integrin antagonists
2. 11685737 - Fluorinated integrin antagonists
3. 11046651 - Piperazine substituted azapine derivatives and uses thereof
4. 10155758 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
5. 10106537 - Fluorinated integrin antagonists
6. 10053453 - Compounds and their use as BACE inhibitors
7. 9895340 - Fluorinated benzofuran derivatives
8. 9802933 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
9. 9717729 - Fluorinated integrin antagonists
10. 9624189 - Fluorinated benzofuran derivatives
11. 9593114 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives
12. 9556114 - Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives
13. 9518053 - Fluorinated integrin antagonists
14. 9266884 - Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-y1)-3-arylpropanoic acid derivatives
15. 8916133 - Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives